Joe Renny, Head of Corporate Development at CatSci, returns to Trailblazers to explore whether a new Cold War is emerging around pharmaceutical innovation. He and Perry Rearick discuss China’s growing role in drug discovery, the push for scientific and supply chain sovereignty, the future of IP and patent protection, and how AI could increase productivity without replacing the human expertise needed to turn science into medicines.
AI Is Driving Epoch Changes To The Buyer’s Journey
Andy Briney, Chief Product Officer, and Will Rompala, Chief Technology Officer at Life Science Connect, join Trailblazers to discuss how AI is changing the buyer's journey. Buyers are adopting AI faster than many companies can adapt, and Andy and Will share how Life...



